Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Our e-services for applications, projects and assessments (the eServices portal) close on Thursday 26 January at 4:30pm because of system upgrades. We expect to open them again on Friday 27 January at 8am the latest.

Clinical Verification of Innovative Product that Facilitates Intravenous Access

Reference number
Coordinator Ortrud Medical AB
Funding from Vinnova SEK 142 424
Project duration December 2016 - December 2017
Status Completed

Purpose and goal

The project goal was to examine and develop the prototype alongside the end user to ensure its readiness for production and use in the clinic. It was successfully verified with the end user at the clinic and in the lab. We have performed several rounds of optimisation for production in order to reach readiness for production at the level required for the CE mark, which allows clinical trials and sales.

Expected results and effects

The project has verified that the product meets the demand of the end user in terms of user friendliness as well as functionality in the clinic. Following this project, functionality has increased and product versions for patient sub types were identified. The product is now CE marked and first production is initiated.

Planned approach and implementation

WP2 and 3 were in part performed in parallel as both related to the end user. Both ran within the planned time interval. Since CE-mark work took longer than anticipated, this incurred WP1 delay, causing costs for the clinic to be delayed.

External links

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 25 November 2019

Reference number 2016-04185

Page statistics